Journal of Vascular Surgery
Volume 52, Issue 3 , Pages 576-583.e2 , September 2010

CAPTURE 2 risk-adjusted stroke outcome benchmarks for carotid artery stenting with distal embolic protection

  • Jon S. Matsumura, MD

      Affiliations

    • Division of Vascular Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisc
    • Corresponding Author InformationReprint requests: Jon S. Matsumura, MD, Division of Vascular Surgery, University of Wisconsin School of Medicine and Public Health, G5/325 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792
    • ,
  • William Gray, MD

      Affiliations

    • Center for Interventional Vascular Therapy, Columbia University, New York, NY
    • ,
  • Seemant Chaturvedi, MD

      Affiliations

    • Wayne State University, Detroit, Mich
    • ,
  • Xingyu Gao, MS

      Affiliations

    • Abbott Vascular, Endovascular Clinical Science, Santa Clara, Calif
    • ,
  • Jin Cheng, MD, PhD

      Affiliations

    • Abbott Vascular, Endovascular Clinical Science, Santa Clara, Calif
    • ,
  • Patrick Verta, MD

      Affiliations

    • Abbott Vascular, Endovascular Clinical Science, Santa Clara, Calif
    • ,
  • CAPTURE 2 Investigators and Executive Committee

Received 2 October 2009 ,Accepted 25 March 2010.

References 

  1. [No authors listed] North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453
  2. [No authors listed] Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379–1387
  3. [No authors listed] Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421–1428
  4. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363:1491–1502
  5. [No authors listed] Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001;357:1729–1737
  6. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493–1501
  7. Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008;358:1572–1579
  8. Eckstein HH, Ringleb P, Allenberg JR, Berger J, Fraedrich G, Hacke W, et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol. 2008;7:893–902
  9. Mas JL, Trinquart L, Leys D, Albucher JF, Rousseau H, Viguier A, et al. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3s) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol. 2008;7:885–892
  10. Featherstone RL, Brown MM, Coward LJ ICSS Investigators. International carotid stenting study: protocol for a randomised clinical trial comparing carotid stenting with endarterectomy in symptomatic carotid artery stenosis. Cerebrovasc Dis. 2004;18:69–74
  11. http://www.nih.gov/news/health/feb2010/ninds-26.htmAccessed March 10, 2010
  12. Carotid stenting vs. Surgery of severe carotid artery disease and stroke prevention in asymptomatic patients (ACT I). www.clinicaltrials.gov/ct2/show/NCT00106938?term=ACT+and+stent&rank=22009;Accessed May 7, 2010
  13. Rosenfield K, Babb JD, Cates CU, Cowley MJ, Feldman T, Gallagher A, et al. Clinical competence statement on carotid stenting: training and credentialing for carotid stenting--multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS writing committee to develop a clinical competence statement on carotid interventions. J Am Coll Cardiol. 2005;45:165–174
  14. Creager MA, Goldstone J, Hirshfeld JW, Kazmers A, Kent KC, Lorell BH, et al. ACC/ACP/SCAI/SVMB/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology/American Heart Association/American College of Physician Task Force on Clinical Competence (ACC/ACP/SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on peripheral vascular disease). J Am Coll Cardiol. 2004;44:941–957
  15. Barr JD, Connors JJ, Sacks D, Wojak JC, Becker GJ, Cardella JF, et al. Quality improvement guidelines for the performance of cervical carotid angioplasty and stent placement (Developed by a collaborative panel of the American Society of Interventional and Therapeutic Neuroradiology, the American Society of Neuroradiology, and the Society of Interventional Radiology). J Vasc Interv Radiol. 2003;14(9 Pt 1):1079–1093
  16. Connors JJ, Sacks D, Furlan AJ, Selman WR, Russell EJ, Stieg PE, et al. Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention. AJNR Am J Neuroradiol. 2004;25:1732–1741
  17. Gray WA, Yadav JS, Verta P, Scicli A, Fairman R, Wholey M, et al. The CAPTURE registry: predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting. Catheter Cardiovasc Interv. 2007;70:1025–1033
  18. Chaturvedi S, Matsumura JS, Gray W, Xu C, Verta P CAPTURE 2 Investigators and Executive Committee. Carotid artery stenting in octogenarians: periprocedural stroke risk predictor analysis from the multicenter carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events (CAPTURE 2) clinical trial. Stroke. 2010;41:757–764
  19. Massop D, Dave R, Metzger C, Bachinsky W, Solis M, Shah R, et al. Stenting and angioplasty with protection in patients at high-risk for endarterectomy: SAPPHIRE Worldwide Registry first 2,001 patients. Catheter Cardiovasc Interv. 2009;73:129–136
  20. Safian RD, Bresnahan JF, Jaff MR, Foster M, Bacharach JM, Maini B, et al. Protected carotid stenting in high-risk pateints with severe carotid artery stenosis. J Am Coll Cardiol. 2006;47:2384–2389
  21. Gröschel K, Ernemann U, Schnaudigel S, Wasser K, Nägele T, Kastrup A. A risk score to predict ischemic lesions after protected carotid artery stenting. J Neurol Sci. 2008;273:112–115
  22. Paciaroni M, Eliasziw M, Kappelle LJ, Finan JW, Ferguson GG, Barnett HJ. Medical complications associated with carotid endarterectomy (North American Symptomatic Carotid Endarterectomy Trial (NASCET)). Stroke. 1999;30:1759–1763
  23. Bond R, Narayan SK, Rothwell PM, Warlow CP European Carotid Surgery Trialists' Collaborative Group. Clinical and radiographic risk factors for operative stroke and death in the European carotid stroke trial. Eur J Vasc Endovasc Surg. 2002;23:108–116
  24. Gray WA, Chaturvedi S, Verta P Investigators and the Executive Committees. Thirty-day outcomes for carotid artery stenting in 6320 patients from 2 prospective, multicenter, high-surgical-risk registries. Circ Cardiovasc Interv. 2009;2:159–166
  25. Schonholz C, Uflacker R, Guimaraes M EMPIRE Investigators. GORE EMPIRE clinical trial results using the Gore flow reversal system during carotid artery stenting. Abstract presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting and Postgraduate Course; September 19-23, 2009; Lisbon, Portugal Cardiovascular & Interventional Radiology. 2009;32(Supplement 2):288;Abstract 1203.4
  26. Evaluating the use of the Fibernet embolic protection device in carotid artery stenting: The epic european study. http://www.clinicaltrials.gov/ct2/show/NCT00309803?term=EPIC&rank=112008;Accessed May 7, 2010
  27. Chaturvedi S, Gray WA, Matsumura J. Safety outcomes from the PROTECT carotid artery stenting multi-center study. Stroke. 2009;40:e107

 Competition of interest: Dr Matsumura received research support, consultation fees, or training director fees from Abbott, Cook, EV3, Lumen, Medtronic, and WL Gore. Dr Cheng is an employee of sponsor for the clinical trial (Abbott), and Dr Gao and Dr Verta are employees of Abbott.

 Additional material for this article may be found online at www.jvascsurg.org.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(10)00811-6

doi: 10.1016/j.jvs.2010.03.064

Journal of Vascular Surgery
Volume 52, Issue 3 , Pages 576-583.e2 , September 2010

Article Tools

* Image Usage & Resolution